Insulet Corporation Profile Avatar - Palmy Investing

Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a tim…
Medical - Devices
US, Acton [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
27.71 45.09 43.82 43.68 45.49 49.63 50.50 57.52 59.76 65.65 65.06 64.39 68.45 61.72 68.35
Profit Margin
-120.46 -63.07 -37.55 -24.54 -18.20 -17.84 -27.86 -7.87 -5.79 0.58 1.57 0.75 1.53 0.35 12.16
Operating Margin
-89.89 -39.84 -27.89 -17.02 -11.79 -4.26 -18.47 -2.92 -1.59 4.86 2.99 -0.07 6.07 -2.05 12.96
EPS Growth
20.24 42.54 20.78 11.48 23.15 -12.05 -38.71 61.24 8.00 112.15 239.89 -42.11 127.27 -73.48 4,364.56
Return on Assets (ROA)
-46.34 -39.15 -27.28 -26.19 -15.62 -17.04 -26.72 -6.32 -3.29 0.35 1.01 0.36 0.82 0.20 7.97
Return on Equity (ROE)
-150.48 -92.34 -80.07 -117.41 -36.10 -61.43 -215.91 -45.73 -16.93 1.55 15.28 1.13 3.02 0.97 28.16
Return on Invested Capital (ROIC)
-37.02 -38.66 -22.05 -22.25 -11.86 -4.77 -23.12 -2.74 -1.03 2.15 1.83 -0.03 2.99 -0.67 10.62
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
56.50 44.44 58.02 59.66 42.26 57.80 64.51 72.93 69.32 63.74 78.00 56.56 62.18 62.27 54.84
Debt/Equity
183.47 104.84 170.32 267.47 97.66 208.33 521.24 527.38 357.17 279.11 1,174.57 175.50 229.00 294.25 193.71
Debt/EBITDA
52.25 147.26 -52.29 -169.21 96.27 -190.65 -166.91 -348.89 -1,707.28 1,105.03 1,023.60 175.37 368.41 1,992.06 362.77
Debt/Capitalization
64.72 51.18 63.01 72.79 49.41 67.57 83.90 84.06 78.13 73.62 92.15 63.70 69.60 74.64 65.95
Interest Debt per Share USD
3.94 2.33 2.92 2.80 2.57 3.40 3.35 6.13 10.09 10.43 15.16 17.06 19.72 20.59 19.83
Debt Growth
14.09 -28.40 56.32 8.86 2.98 43.52 1.63 87.64 70.00 4.56 49.99 17.55 19.65 12.25 3.35
Liquidity
Current Ratio
778.80 751.75 470.74 227.68 467.73 470.01 292.78 664.24 624.44 398.84 374.76 600.91 581.21 360.30 347.14
Quick Ratio
721.54 686.62 418.45 187.61 431.38 431.36 253.55 877.55 768.27 467.47 393.98 515.78 416.35 255.31 235.79
Cash Ratio
646.02 597.75 335.61 118.65 353.35 341.32 188.27 536.06 511.54 249.83 238.49 456.02 345.98 185.00 144.22
Operating Cash Flow Ratio
-200 -100 - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
473.28 465.79 722.61 800.65 1,423.11 1,110.25 1,086.34 438.99 552.18 271.17 255.35 208.75 114.35 144.09 133.43
Receivables Turnover
441.33 575.77 656.56 634.86 747.22 723.94 620.49 1,274.14 868.92 735.37 891.55 1,079.24 682.48 634.87 471.81
Payables Turnover
813.20 1,087.64 749.19 1,271.58 695.71 992.10 858.62 1,184.67 764.34 759.43 473.21 595.38 919.63 1,622.40 2,797.92
Asset Turnover
38.47 62.06 72.65 106.72 85.81 95.55 95.92 80.37 56.78 60.71 64.59 48.29 53.63 57.98 65.57
Coverage
Interest Coverage
-294.12 -170.23 -288.60 -227.75 -169.25 -83.73 -383.39 -74.40 -38.50 123.54 82.46 -1.33 108.99 -100.00 -607.73
Asset Coverage
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Cash Flow Coverage (CFGR)
-50.86 -51.31 -20.93 -24.59 2.75 5.11 -7.07 4.78 7.28 6.06 11.04 7.93 -5.35 8.49 10.24
EBITDA Coverage
-200 -100 -100 -200 -100 - - -200 - - - - 100 100 100 200 100 -600
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
- - - - - - - - - - - - - - - - - - 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
-18.74 -9.96 -6.50 -5.10 -2.24 -2.01 -3.42 -1.35 -0.67 0.07 0.11 0.04 0.09 0.02 1.36
Price/Earnings (P/E)
-533.69 -1,003.81 -1,537.82 -1,960.70 -4,455.47 -4,975.24 -2,920.38 -7,396.33 -14,916.47 141,821.85 89,428.16 243,356.00 107,216.71 443,984.92 7,336.20
Price/Book (P/B)
803.12 926.94 1,231.40 2,302.05 1,608.23 3,056.52 6,305.44 3,382.40 2,524.82 2,201.22 13,667.54 2,741.59 3,237.89 4,287.01 2,065.59
Price/Sales (P/S)
642.87 633.13 577.43 481.13 810.98 887.45 813.61 582.03 862.98 828.06 1,405.27 1,829.74 1,639.28 1,564.64 891.79
Price/Cash Flow (P/CF)
-860.66 -1,723.29 -3,454.23 -3,499.62 59,850.77 28,724.78 -17,105.36 13,424.58 9,712.52 13,005.31 10,542.34 19,700.25 -26,449.94 17,162.44 10,408.92
End of PODD's Analysis
CIK: 1145197 CUSIP: 45784P101 ISIN: US45784P1012 LEI: - UEI: -
Secondary Listings
PODD has no secondary listings inside our databases.